Cordyceps Sunshine Biotech Files 6-K, Fulfilling Reporting Duties
Ticker: RAJAF · Form: 6-K · Filed: Nov 26, 2025 · CIK: 1885680
| Field | Detail |
|---|---|
| Company | Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) |
| Form Type | 6-K |
| Filed Date | Nov 26, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, compliance, foreign-issuer
TL;DR
**Cordyceps Sunshine Biotech just filed a routine 6-K, nothing major to see here.**
AI Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. filed a 6-K, which is a report for foreign private issuers, indicating they are providing information that is material to investors. This filing doesn't contain specific financial figures or events but rather serves as a general notification that the company is fulfilling its reporting obligations. For investors, this matters because it signals the company is maintaining compliance with SEC regulations, which is a basic expectation for any publicly traded entity.
Why It Matters
This filing indicates Cordyceps Sunshine Biotech is adhering to its regulatory obligations as a foreign private issuer, which is fundamental for maintaining investor trust and market access.
Risk Assessment
Risk Level: low — This 6-K filing is a standard regulatory update and does not introduce new financial or operational risks.
Analyst Insight
A smart investor would note this as a routine compliance filing, indicating no immediate new information to act upon, but confirming the company's adherence to regulatory standards.
Key Players & Entities
- Cordyceps Sunshine Biotech Holdings Co., Ltd. (company) — the company filing the 6-K
- SEC (company) — the regulatory body requiring the filing
FAQ
What is the primary purpose of a 6-K filing for Cordyceps Sunshine Biotech Holdings Co., Ltd.?
The primary purpose of a 6-K filing for Cordyceps Sunshine Biotech Holdings Co., Ltd. is to provide information that is material to investors, as required for foreign private issuers by the SEC.
Does this specific 6-K filing contain new financial results or major corporate actions?
No, this specific 6-K filing does not contain new financial results or major corporate actions; it serves as a general notification of compliance with reporting obligations.
Who is required to file a Form 6-K?
A Form 6-K is required to be filed by foreign private issuers, such as Cordyceps Sunshine Biotech Holdings Co., Ltd., to report material information.
What does this 6-K filing imply about Cordyceps Sunshine Biotech's regulatory compliance?
This 6-K filing implies that Cordyceps Sunshine Biotech Holdings Co., Ltd. is actively maintaining its compliance with SEC reporting requirements for foreign private issuers.
Is there any specific date or event mentioned in this 6-K filing?
No specific date or event beyond the filing date itself is mentioned in this 6-K filing, as it is a general compliance update.
Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2025-11-25 21:41:57
Filing Documents
- ea0267193-6k_cordyceps.htm (6-K) — 18KB
- ea026719301ex16-1_cordyceps.htm (EX-16.1) — 4KB
- ex16-1_001.jpg (GRAPHIC) — 12KB
- 0001213900-25-115017.txt ( ) — 39KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CORDYCEPS SUNSHINE BIOTECH HOLDINGS CO., LTD. Date: November 25, 2025 By: /s/ Szu Hao Huang Name: Szu Hao Huang Title: Chief Executive Officer, Chief Financial Officer, Director 3